IBB ETF holdings (NASDAQ) - Page 7 | MetaTrader

Apri il grafico completo

Panoramica Tutti gli asset Mappa di calore

Principali partecipazioni Market Value Shares Weight %

GLUE Monte Rosa Therapeutics, Inc. 10.04 M 414.84 K 0.11%

NUVB Nuvation Bio, Inc. 9.90 M 1.74 M 0.11%

VIR Vir Biotechnology, Inc. 9.67 M 949.16 K 0.11%

IMCR Immunocore Holdings plc 9.50 M 299.29 K 0.10%

CDNA CareDx, Inc. 9.38 M 329.01 K 0.10%

GHRS GH Research plc 9.30 M 345.89 K 0.10%

MNKD MannKind Corp. 8.85 M 2.08 M 0.10%

Lakefront Biotherapeutics NV 8.77 M 292.58 K 0.10%

RAPP Rapport Therapeutics, Inc. 8.36 M 200.63 K 0.09%

SION Sionna Therapeutics, Inc. 8.17 M 185.69 K 0.09%

AVBP ArriVent Biopharma, Inc. 8.01 M 230.49 K 0.09%

XNCR Xencor, Inc. 7.94 M 492.92 K 0.09%

BCAX Bicara Therapeutics, Inc. 7.87 M 264.97 K 0.09%

INBX Inhibrx Biosciences, Inc. 7.26 M 76.63 K 0.08%

MAZE Maze Therapeutics, Inc. 7.24 M 242.76 K 0.08%

PHVS Pharvaris NV 7.17 M 207.30 K 0.08%

WaVe Life Sciences Ltd. 6.93 M 1.19 M 0.08%

STVN Stevanato Group SpA 6.74 M 372.91 K 0.07%

MESO Mesoblast Ltd. 6.70 M 495.41 K 0.07%

MGTX MeiraGTx Holdings plc 6.68 M 494.68 K 0.07%

1
...
5
6
7
8
9
10
...
13

Notizie

UBS elenca 5 motivi chiave per cui le azioni biotech a media capitalizzazione dovrebbero performare bene nel 2026